Drug Solutions Podcast: Sourcing Autologous and Allogeneic Cell Therapies
In this episode of the Drug Solutions Podcast, Meg Rivers, senior editor, interviews Joy Aho, senior product manager at Be The Match BioTherapies, about sourcing autologous and allogeneic cell therapies.
In this episode of the Drug Solutions Podcast, Meg Rivers, senior editor, interviews Joy Aho, senior product manager at Be The Match BioTherapies, about sourcing autologous and allogeneic cell therapies, including discussions on:
- Current sourcing options for biopharma companies in the cell therapy space
- Key considerations when deciding what sourcing method is best for an individual therapy
- Considerations for donor identification and cell collection
- Potential collection network strategies for cell therapy, and how these strategies impact quality, agility, and scalability
- Vendors for cell therapy and supply chain impacts
About the speaker
Joy Aho, PhD, is the senior product manager at Be The Match BioTherapies, where she develops innovative products and services for the cell and gene therapy industry.
About the Drug Solutions Podcast
Pharmaceutical Technology presents the Drug Solutions podcast, where the editors will chat with industry experts from across the pharmaceutical and biopharmaceutical supply chain. Join us as experts share insights into your biggest questions—from the technologies, to strategies, to regulations related to the development and manufacture of drug products.
Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.
